跳至主要内容
临床试验/NCT05291299
NCT05291299招募中不适用

Anti-Inflammatory Dietary Intervention for Rheumatoid Arthritis

Attune Health Research, Inc.2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2022年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
32
试验地点
2
主要终点
Disease Activity

研究概览

简要总结

The primary objective of this study is to assess if there is a significant difference in the mean disease activity score in individuals with RA participating in a dietary intervention compared to those in the control group measured by DAS-28. Other measures to track disease activity will include monitoring number and severity of disease flares and any changes in medications. This will be done by completing a single-blinded randomized controlled trial, parallel in design. The study population will consist of adults diagnosed with Seropositive and Seronegative RA based on the American College of Rheumatology criteria. Participants will have low, moderate, or high disease activity based on DAS-28 where the investigator feels that they can see improvement from a dietary intervention.

详细描述

Per the Schedule of Assessments, upon enrollment, participants will be required to come in for a total of five on site visits. The first visit, also known as the baseline visit, will require participants to provided informed consent after all eligibility criteria is met. Subsequently, participants' Demographics, Medical History, EULAR/ACR classification, and physicians' assessments will be documented. Participants' vital signs will be checked and a thorough physical exam will also be performed after which safety labs will be drawn in addition to a routine urinalysis. Participants will complete outcome surveys and a food frequency questionnaire. Participants' body composition will be measured. Concomitant medications will be reviewed. Each participant will receive nutrition education from an approved MD or a consultation with an approved RD depending on the group to which they have been randomized. Participants who receive consultations with an RD will have seven follow up visits after the baseline visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years.
  • Diagnosed RA by a rheumatologist determined by the 2010 ACR/EULAR Classification Criteria.
  • Low, moderate, or highly active disease state based on clinical assessment where the investigator feels there is potential to see a difference.
  • Able to read and write in English.

排除标准

  • Younger than 18 years.
  • Unable to attend the 8 weekly nutrition appointment.
  • History of documented eating disorders.

结局指标

主要结局

Disease Activity

时间窗: 52 weeks

Rheumatoid arthritis disease activity Measured by Disease Activity Score-28, higher score is associated with increased disease activity. a Disease Activity Score greater than 5.1 indicated very active disease while a Disease Activity Score that is lower than 2.6 indicates disease remission

次要结局

  • Anthropometric measurements(52 weeks)
  • Patient reported outcomes(52 weeks)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Swamy Venuturupalli

Principal Investigator

Attune Health Research, Inc.

研究点 (2)

Loading locations...

相似试验